Treace James T. - 25 May 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Jaime A. Frias as Attorney-in-fact for James T. Treace
Issuer symbol
TMCI
Transactions as of
25 May 2022
Net transactions value
-$775,858
Form type
4
Filing time
27 May 2022, 18:39:45 UTC
Previous filing
14 Mar 2022
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $465,323 -30,313 -2.2% $15.35 1,356,128 25 May 2022 Direct F1, F2
transaction TMCI Common Stock Sale $310,535 -19,687 -1.5% $15.77 1,336,441 26 May 2022 Direct F1, F3
holding TMCI Common Stock 556,183 25 May 2022 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.71 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.33 to $16.015 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.